CiteFacts · FDA Drug Shortages · FDA source
FDA shortage status: Dextrose Monohydrate 10% Injection
FDA source answer
FDA currently lists this ingredient in shortage.
FDA source statuses: Current. First FDA posting: 2022-03-01. Latest FDA row update: 2026-10-02.
FDA lists 13 package records, with companies: B. Braun Medical Inc., Baxter Healthcare, Baxter Healthcare Corporation, Fresenius Kabi USA, LLC, ICU Medical, Inc., Otsuka ICU Medical LLC. Package NDCs: 0264-7520-00, 0264-7520-10, 0264-7520-20, 0338-0023-02, 0338-0023-03, 0338-0023-04, 0990-7930-02, 0990-7930-03, 0990-7930-09, 0990-7938-19, 63323-824-74, 63323-824-75, 63323-824-76.
FDA shortage reason: Discontinuation of the manufacture of the drug
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Package NDC | Presentation | FDA availability field | FDA update |
|---|---|---|---|---|
| B. Braun Medical Inc. | 0264-7520-00 | Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-00) | Available | 2026-09-22 |
| B. Braun Medical Inc. | 0264-7520-10 | Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-10) | Available | 2026-09-22 |
| B. Braun Medical Inc. | 0264-7520-20 | Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-20) | Available | 2026-09-22 |
| Baxter Healthcare | 0338-0023-02 | Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-02) | Available | 2026-10-02 |
| Baxter Healthcare | 0338-0023-03 | Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-03) | Available | 2026-10-02 |
| Baxter Healthcare | 0338-0023-04 | Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-04) | Available | 2026-10-02 |
| Fresenius Kabi USA, LLC | 63323-824-74 | Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-74) | Available | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-824-75 | Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-75) | Available | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-824-76 | Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-76) | Available | 2026-09-15 |
| Otsuka ICU Medical LLC | 0990-7930-02 | Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-02) | Available | 2026-10-01 |
| Otsuka ICU Medical LLC | 0990-7930-03 | Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-03) | Available | 2026-10-01 |
| Otsuka ICU Medical LLC | 0990-7930-09 | Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-09) | Available | 2026-10-01 |
| Otsuka ICU Medical LLC | 0990-7938-19 | Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7938-19) | Unavailable | 2026-10-01 |
Source facts
Grouped generic ingredient: Dextrose Monohydrate 10% Injection · 13 package records
Therapeutic categories: Endocrinology/Metabolism, Gastroenterology, Other, Pediatric
Dosage forms: Injection
Routes: INTRAVENOUS
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-10-06T18:55:41+00:00. Derived grouping is documented in this record's derivations.